Lung cancer vaccine renews synthetic DNA discussions
pharmaphorum spoke with Dr Amy Walker, CEO of 4basebio, about personalised cancer vaccines and synthetic DNA.
Newsletters and Deep Dive digital magazine
pharmaphorum spoke with Dr Amy Walker, CEO of 4basebio, about personalised cancer vaccines and synthetic DNA.
In oncology, time is not simply a measure of care; it is a clinical variable – and increasingly a therapeutic challenge.
Too often, oncology trials fail for reasons that could have been anticipated and addressed.
As AI adoption increases, it is exposing just how prepared organisations really are to operate in a digitally connected environment.
Report turnaround time has become a key metric for diagnostic centres, shaping much of the automation built around their work.
Editor's Picks
Newsletters and Deep Dive
digital magazine